Ananda Developments Plc (ANA) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Jun 2024 01:27 PM
RNS
Extension of Mark Ling as Senior Statutory Auditor
31 May 2024 07:00 AM
RNS
Ananda joins cannabinoid R&D Group
30 May 2024 07:00 AM
RNS
Quarterly Trading Statement to 30 April 2024
14 May 2024 07:00 AM
RNS
Ananda Presentation to LSX Conference 2024
02 May 2024 12:00 PM
RNS
Response to FSA-FSS Cannabidiol Safety Assessment
21 Mar 2024 07:00 AM
RNS
Establishment of Scientific Advisory Board
28 Feb 2024 07:00 AM
RNS
Endometriosis Trial Drug Supply Agreement Signed
26 Feb 2024 12:00 PM
RNS
Ananda presenting at Master Investor Show
26 Feb 2024 07:00 AM
RNS
Quarterly Trading Statement to 31 January 2024
06 Feb 2024 07:00 AM
RNS
Appointment of Adviser
23 Jan 2024 07:00 AM
RNS
Appointment of Scientific Advisers
14 Dec 2023 07:00 AM
RNS
Ananda Launches New Interactive Investor Hub
29 Nov 2023 02:39 PM
RNS
Quarterly Trading Statement to 31 October 2023
14 Nov 2023 07:00 AM
RNS
Drug Supply Agreement Signed
08 Nov 2023 07:30 AM
RNS
Investor Presentation via Investor Meet Company
08 Nov 2023 07:00 AM
RNS
THC Oil Patent Application Filed
01 Nov 2023 07:00 AM
RNS
MOU signed with Nottingham Trent University
24 Oct 2023 02:20 PM
RNS
Interim Results to 31 July 2023
06 Sep 2023 07:00 AM
RNS
Issue of Convertible Loan Notes
31 Aug 2023 07:00 AM
RNS
Shareholder Update
25 Aug 2023 12:01 PM
RNS
Research Roundup
25 Aug 2023 12:01 PM
RNS
Research Roundup
24 Aug 2023 02:28 PM
RNS
Result of AGM
15 Aug 2023 07:00 AM
RNS
NHS SCOTLAND TO FUND MRX1 ENDOMETRIOSIS TRIAL
31 Jul 2023 05:44 PM
RNS
Completion of Audit & Notice of AGM
27 Jul 2023 07:00 AM
RNS
First Cannabinoid Medicines Launched
13 Jul 2023 10:22 AM
RNS
Unaudited Preliminary Results
26 Jun 2023 07:00 AM
RNS
Operational Update
23 Jun 2023 08:30 AM
RNS
Research Round Up
17 May 2023 07:00 AM
RNS
Patent Applications Filed
05 May 2023 10:19 AM
PRN
Shareholder Update, CLN Redemption, Warrant E...
UK 100

Latest directors dealings